Translate AMICOR contents if you like

Saturday, January 16, 2016

Diclofenac and cancer

Could this common painkiller become a future cancer-killer?
January 12, 2016

(credit: iStock) Diclofenac, a common painkiller, has significant anti-cancer properties, researchers from the Repurposing Drugs in Oncology (ReDO) project have found. ReDO, an international collaboration between the Belgium-based Anticancer Fund and the U.S.- based GlobalCures, has published their investigation into diclofenac in the open-access journal ecancermedicalscience. Diclofenac is a well-known non-steroidal anti-inflammatory drug (NSAID) widely used to treat pain … more…

No comments: